Home  /  Resource Library  /  Lenalidomide with Rituximab for Previously Treated Follicular Lymphoma and Marginal Zone Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

Lenalidomide with Rituximab for Previously Treated Follicular Lymphoma and Marginal Zone Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

Results of a technology appraisal investigating lenalidomide combined with rituximab for treatment of relapsed follicular and marginal zone lymphomas.